Literature DB >> 16714288

Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from Sulfolobus solfataricus.

Marco Marino1, Miriam Deuss, Dmitri I Svergun, Petr V Konarev, Reinhard Sterner, Olga Mayans.   

Abstract

The metabolic synthesis and degradation of essential nucleotide compounds are primarily carried out by phosphoribosyltransferases (PRT) and nucleoside phosphorylases (NP), respectively. Despite the resemblance of their reactions, five classes of PRTs and NPs exist, where anthranilate PRT (AnPRT) constitutes the only evolutionary link between synthesis and degradation processes. We have characterized the active site of dimeric AnPRT from Sulfolobus solfataricus by elucidating crystal structures of the wild-type enzyme complexed to its two natural substrates anthranilate and 5-phosphoribosyl-1-pyrophosphate/Mg(2+). These bind into two different domains within each protomer and are brought together during catalysis by rotational domain motions as shown by small angle x-ray scattering data. Steady-state kinetics of mutated AnPRT variants address the role of active site residues in binding and catalysis. Results allow the comparative analysis of PRT and pyrimidine NP families and expose related structural motifs involved in nucleotide/nucleoside recognition by these enzyme families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714288     DOI: 10.1074/jbc.M601403200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  YbiB from Escherichia coli, the Defining Member of the Novel TrpD2 Family of Prokaryotic DNA-binding Proteins.

Authors:  Daniel Schneider; Wolfgang Kaiser; Cian Stutz; Alexandra Holinski; Olga Mayans; Patrick Babinger
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

Review 2.  Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance.

Authors:  Bjarne Hove-Jensen; Kasper R Andersen; Mogens Kilstrup; Jan Martinussen; Robert L Switzer; Martin Willemoës
Journal:  Microbiol Mol Biol Rev       Date:  2016-12-28       Impact factor: 11.056

3.  Anthranilate phosphoribosyl transferase (TrpD) generates phosphoribosylamine for thiamine synthesis from enamines and phosphoribosyl pyrophosphate.

Authors:  Jennifer A Lambrecht; Diana M Downs
Journal:  ACS Chem Biol       Date:  2012-11-02       Impact factor: 5.100

4.  Neisseria meningitidis expresses a single 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase that is inhibited primarily by phenylalanine.

Authors:  Penelope J Cross; Amy L Pietersma; Timothy M Allison; Sarah M Wilson-Coutts; Fiona C Cochrane; Emily J Parker
Journal:  Protein Sci       Date:  2013-06-27       Impact factor: 6.725

5.  Synthetic inositol phosphate analogs reveal that PPIP5K2 has a surface-mounted substrate capture site that is a target for drug discovery.

Authors:  Huanchen Wang; Himali Y Godage; Andrew M Riley; Jeremy D Weaver; Stephen B Shears; Barry V L Potter
Journal:  Chem Biol       Date:  2014-04-24

6.  Anthranilate phosphoribosyltransferase from the hyperthermophilic archaeon Thermococcus kodakarensis shows maximum activity with zinc and forms a unique dimeric structure.

Authors:  Sumera Perveen; Naeem Rashid; Xiao-Feng Tang; Tadayuki Imanaka; Anastassios C Papageorgiou
Journal:  FEBS Open Bio       Date:  2017-07-24       Impact factor: 2.693

7.  Datasets, processing and refinement details for Mtb-AnPRT: inhibitor structures with various space groups.

Authors:  Genevieve L Evans; Daniel P Furkert; Nacim Abermil; Preeti Kundu; Katrina M de Lange; Emily J Parker; Margaret A Brimble; Edward N Baker; J Shaun Lott
Journal:  Data Brief       Date:  2017-10-31

8.  Crystal structures of anthranilate phosphoribosyltransferase from Saccharomyces cerevisiae.

Authors:  Xiaofei Wu; Mengying Zhang; Zhiling Kuang; Jian Yue; Lu Xue; Min Zhu; Zhongliang Zhu; Muhammad Hidayatullah Khan; Liwen Niu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2021-03-03       Impact factor: 1.056

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.